A phase 2 study of Depigoid Birch pollen extract for patients with rhinoconjuctivitis during the European 2006 birch pollen season.
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2010
At a glance
- Drugs Birch pollen allergy immunotherapy (Primary)
- Indications Allergic rhinoconjunctivitis
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.